Cargando…

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease

INTRODUCTION: BrainAge models based on neuroimaging data have diagnostic classification power but have replicability issues due to site and patient variability. BrainAge models trained on neuropsychological tests could help distinguish stable mild cognitive impairment (sMCI) from progressive MCI (pM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia Condado, Jorge, Cortes, Jesus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614125/ https://www.ncbi.nlm.nih.gov/pubmed/37908437 http://dx.doi.org/10.1002/dad2.12493

Ejemplares similares

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease
por: Gaser, Christian, et al.
Publicado: (2013)

Neuropsychic effects of organic solvents: a review of the Tunisian literature
por: Ziedi, H., et al.
Publicado: (2023)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020)

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020)

Predictive models for mild cognitive impairment to Alzheimer’s disease conversion
por: Skolariki, Konstantina, et al.
Publicado: (2021)

Detecting conversion from mild cognitive impairment to Alzheimer’s disease using FLAIR MRI biomarkers
por: Crystal, Owen, et al.
Publicado: (2023)

Detection of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Longitudinal Brain MRI
por: Sun, Zhuo, et al.
Publicado: (2017)

Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2017)

Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
por: Wheeler, Paul Loyd, et al.
Publicado: (2021)

Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods
por: Sörensen, Arnd, et al.
Publicado: (2020)

USING SERIAL TRICHOTOMIZATION WITH NEUROPSYCH MEASURES TO INFORM DECISIONS ON FITNESS TO DRIVE AMONG OLDER ADULTS
por: Yamin, Stephanie, et al.
Publicado: (2019)

Prediction of Conversion From Amnestic Mild Cognitive Impairment to Alzheimer's Disease Based on the Brain Structural Connectome
por: Sun, Yu, et al.
Publicado: (2019)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
por: Koh, Seong-Ho, et al.
Publicado: (2020)

Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors
por: Cui, Yue, et al.
Publicado: (2011)

Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
por: Young, Jonathan, et al.
Publicado: (2013)

A Two-Stage Model for Predicting Mild Cognitive Impairment to Alzheimer’s Disease Conversion
por: Lu, Peixin, et al.
Publicado: (2022)

Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion
por: Li, Ying, et al.
Publicado: (2021)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Cerebrospinal Biomarker Cut-off Methods Defined Only by Alzheimer's Disease Predict More Precisely Conversions of Mild Cognitive Impairment
por: Kim, Jong Hun, et al.
Publicado: (2017)

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment
por: Martínez-Torteya, Antonio, et al.
Publicado: (2015)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
por: Löwe, Luise Christine, et al.
Publicado: (2016)

Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
por: Defrancesco, Michaela, et al.
Publicado: (2014)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease
por: Willette, Auriel A., et al.
Publicado: (2015)

Alzheimer's disease: 3-Dimensional MRI texture for prediction of conversion from mild cognitive impairment
por: Luk, Collin C., et al.
Publicado: (2018)

δ scores predict mild cognitive impairment and Alzheimer's disease conversions from nondemented states
por: Royall, Donald R., et al.
Publicado: (2017)

Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment
por: Chaudhury, Sultan, et al.
Publicado: (2019)

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data
por: Kikuchi, Masataka, et al.
Publicado: (2022)

Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
por: Rye, Ingrid, et al.
Publicado: (2022)

Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
por: Zhao, Aonan, et al.
Publicado: (2022)

Cognitive and Structural Correlates of Conversational Speech Timing in Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease: Relevance for Early Detection Approaches
por: De Looze, Céline, et al.
Publicado: (2021)

Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients
por: Lee, Eunjee, et al.
Publicado: (2017)

Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database
por: Ledig, Christian, et al.
Publicado: (2018)

Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brain
por: Kepchia, Devin, et al.
Publicado: (2020)

Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using MRI and Structural Network Features
por: Wei, Rizhen, et al.
Publicado: (2016)

Abnormal Resting-State Functional Connectivity Strength in Mild Cognitive Impairment and Its Conversion to Alzheimer's Disease
por: Li, Yuxia, et al.
Publicado: (2016)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
por: Vinceti, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_328npv4ufgfn7dtsn961lihm21